Immunotherapy First for BRAF-Mutant Melanoma

被引：1
|
作者：
Rose, Suzanne
机构：
来源：
CANCER DISCOVERY | 2022年 / 12卷 / 01期
关键词：
D O I：
10.1158/2159-8290.CD-NB2021-0402
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：10 / 10
页数：1
相关论文
共 50 条
  • [1] Sequential treatment with immunotherapy and BRAF inhibitors in BRAF-mutant advanced melanoma
    Aya, F.
    Fernandez-Martinez, A.
    Gaba, L.
    Victoria, I.
    Tosca, M.
    Pineda, E.
    Gascon, P.
    Prat, A.
    Arance, A.
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2017, 19 (01): : 119 - 124
  • [2] Sequential treatment with immunotherapy and BRAF inhibitors in BRAF-mutant advanced melanoma
    F. Aya
    A. Fernandez-Martinez
    L. Gaba
    I. Victoria
    M. Tosca
    E. Pineda
    P. Gascon
    A. Prat
    A. Arance
    [J]. Clinical and Translational Oncology, 2017, 19 : 119 - 124
  • [3] Sequencing of Targeted Treatment and Immunotherapy in Advanced BRAF-Mutant Melanoma
    Devlin, Olivia
    Oladipo, Olabode
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (12) : 2295 - +
  • [4] Inhibition of BRAF and MEK in BRAF-mutant melanoma
    Smalley, Keiran S. M.
    Sondak, Vernon K.
    [J]. LANCET, 2015, 386 (9992): : 410 - 412
  • [5] Choice of immunotherapy vs. targeted therapy in first line treatment for BRAF-mutant melanoma
    Long, G.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 : 5 - 5
  • [6] BRAF and MEK inhibitors in BRAF-mutant melanoma
    Sharma, Sharan Prakash
    [J]. LANCET ONCOLOGY, 2012, 13 (11): : E468 - E468
  • [7] Combining Targeted Therapy With Immunotherapy in BRAF-Mutant Melanoma: Promise and Challenges
    Hu-Lieskovan, Siwen
    Robert, Lidia
    Moreno, Blanca Homet
    Ribas, Antoni
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (21) : 2248 - 2254
  • [8] Dabrafenib for treatment of BRAF-mutant melanoma
    Kainthla, Radhika
    Kim, Kevin B.
    Falchook, Gerald S.
    [J]. PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2014, 7 : 21 - 29
  • [9] DREAMseq of therapy for BRAF-mutant melanoma
    Killock, David
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2023, 20 (01) : 1 - 1
  • [10] Combined BRAF and MEK inhibition with PD-1 blockade immunotherapy in BRAF-mutant melanoma
    Ribas, Antoni
    Lawrence, Donald
    Atkinson, Victoria
    Agarwal, Sachin
    Miller, Wilson H., Jr.
    Carlino, Matteo S.
    Fisher, Rosalie
    Long, Georgina V.
    Hodi, F. Stephen
    Tsoi, Jennifer
    Grasso, Catherine S.
    Mookerjee, Bijoyesh
    Zhao, Qing
    Ghori, Razi
    Moreno, Blanca Homet
    Ibrahim, Nageatte
    Hamid, Omid
    [J]. NATURE MEDICINE, 2019, 25 (06) : 936 - +
12345